. 2020 Jan 10;9:1502. doi: 10.3389/fonc.2019.01502

Table 2.

Correlations between FUNDC1 and genes markers of B cells, macrophages, and monocytes in GEPIA.

Cell type	Gene marker	LIHC				LUSC
		Tumor		Normal		Tumor		Normal
		R	P	R	P	R	P	R	P
B cell	CD19	0.280	^***	0.320	^***	−0.220	^***	−0.048	0.380
	CD20	0.130	0.015	0.160	0.041	−0.180	^***	−0.190	^**
	CD38	0.300	^***	0.220	^**	−0.210	^***	0.290	^***
M1	NOS2	0.110	0.042	0.260	^**	0.170	^**	−0.300	^***
	ROS	0.060	0.250	0.110	0.160	−0.130	^*	0.360	^***
M2	ARG1	−0.270	^***	0.380	^***	0.073	0.110	−0.160	^*
	MRC1	0.039	0.450	0.350	^***	−0.170	^**	0.320	^***
TAM	HLA–G	0.230	^***	0.350	^***	−0.150	^**	0.130	0.021
	CD80	0.400	^***	0.330	^***	−0.210	^***	−0.240	^***
	CD86	0.390	^***	0.450	^***	−0.180	^***	0.016	0.770
Monocyte	CD14	−0.410	^***	0.190	0.015	−0.230	^***	0.140	^*
	CD16	0.340	^***	0.480	^***	−0.180	^***	0.320	^***

LIHC, liver hepatocellular carcinoma; LUSC, lung squamous cell carcinoma; TAM, tumor-associated-macrophage; Tumor, correlation analysis in tumor tissue of TCGA; Normal, correlation analysis in normal tissue of TCGA.

P < 0.01;

^**

P < 0.001;

^***

P < 0.0001.